3-Mercaptopyruvate Sulfurtransferase Represses Tumor Progression and Predicts Prognosis in Hepatocellular Carcinoma

Meng Li,Qi Jin,Yishu Chen,Jie Zhang,Jianguo Gao,Li Cen,Yiming Lin,Chengfu Xu,Youming Li,Chaohui Yu

DOI: https://doi.org/10.21203/rs.3.rs-531506/v1

2021-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.

What problem does this paper attempt to address?

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study

Jian Guo Shen,Jun Shen,Rong Yue Teng,Lin Bo Wang,Wen He zhao,Qin Chuan Wang

DOI: https://doi.org/10.21203/rs.3.rs-27285/v1

2020-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
3‐Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma

Meng Li,Xin Song,Qi Jin,Yishu Chen,Jie Zhang,Jianguo Gao,Li Cen,Yiming Lin,Chengfu Xu,Xinjue He,Youming Li,Chaohui Yu

DOI: https://doi.org/10.1111/liv.15228

IF: 8.754

2022-03-12

Liver International

Abstract:BACKGROUND AND: AIMS: The prognosis of hepatocellular carcinoma (HCC) remains dismal, and its molecular pathogenesis has not been completely defined. The enzyme 3-mercaptopyruvate sulfurtransferase (MPST) regulates endogenous hydrogen sulfide (H<sub>2</sub> S) biosynthesis. However, the role of MPST in HCC has never been intensively investigated.METHODS: MPST protein expression was analysed in HCC tumour tissues and matched adjacent tissues. The effect of MPST on HCC progression was studied in vitro and in vivo.RESULTS: The mRNA and protein expression of MPST was significantly downregulated in HCC samples compared with their paired nontumour counterparts. A low MPST expression was associated with larger tumour size and a worse overall survival. Overexpression of MPST in HCC cells inhibited cell proliferation and induced apoptosis. MPST overexpression also significantly suppressed the growth of tumour xenografts in nude mice, whereas silencing MPST by intratumour delivery of siRNA substantially promoted tumour growth. Moreover, diethylnitrosamine-induced mouse HCC was aggravated by MPST gene knockout. Mechanistically, MPST suppressed the cell cycle associated with H<sub>2</sub> S production and inhibition of the AKT/FOXO3a/Rb signalling pathway in HCC development. In addition, MPST expression negatively correlated with that of pRb in HCC specimens and the combination of these two parameters is a more powerful predictor of poor prognosis.CONCLUSIONS: MPST may function as a tumour suppressor gene that plays an essential role in HCC proliferation and liver tumorigenesis. It is a candidate predictor of clinical outcome in patients with HCC and may be used as a biomarker and intervention target for new therapeutic strategies.

gastroenterology & hepatology
METTL3 is a Potential Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma

Lijuan Li,Yu Zeng,Xiukun Hou,Gaojian Zhuang,Weijing Hao,Ning Kang,Pengfei Gu,Yu Liu,Zewei Zhao,Lingmei Li,Ming Gao,Xianhui Ruan,Xiangqian Zheng

DOI: https://doi.org/10.21203/rs.3.rs-1440953/v1

2022-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
The Sulfatide/Myb/MEF2C Axis Controls the Malignant Behaviors of Hepatocellular Carcinoma Cells by Modulating Lncay Expression

Mei Hua Chen,Bing Qi,Qian Cai,Jia Wen Sun,Li Fu,Chun Lan Kang,Ming Zhe,Xingzhong Wu

DOI: https://doi.org/10.21203/rs.3.rs-44041/v1

2020-01-01

Abstract:The authors have requested that this preprint be removed from Research Square.
SRSF10 inhibition prevents HCC growth and metastasis and enhances the anti-PD-L1- mediated tumor suppression

Xun-Jiang Luo,Zerui Zhang,Yijun Wang,Mengyu Sun,Dian Hu,Jinling Jiang,Yufei Wang,Xiaoyu Ji,Xiaoping Chen,Zhao Huang,Huifang Liang,Yiwei Li,Bi‐Feng Liu,Yongzhan Nie,Kaichun Wu,Daiming Fan,Danfei Liu,Wenjie Huang,Limin Xia

DOI: https://doi.org/10.21203/rs.3.rs-3205248/v1

2023-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
Supplementary Data from Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3

Xingxin Zhu,Guangyuan Song,Shiyu Zhang,Jun Chen,Xiaoyi Hu,Hai Zhu,Xing Jia,Zequn Li,Wenfeng Song,Jian Chen,Cheng Jin,Mengqiao Zhou,Yongchao Zhao,Haiyang Xie,Shusen Zheng,Penghong Song

DOI: https://doi.org/10.1158/0008-5472.22432368.v1

2023-01-01

Abstract:Supplementary Data from Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3
RETRACTED: S1P3 Promotes Low-Grade Glioma Progression and Affects Tumor Microenvironment Infiltration

Tao Huang,Jingxi Du,Liang Wang,Xuan Xie,Fan Chen

DOI: https://doi.org/10.21203/rs.3.rs-1251483/v3

2022-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
MiR-23b-3p Targeting NCAPG Promotes Cell Proliferation and Anti-Apoptosis By Regulating PI3K/AKT Signaling Pathway in Colorectal Cancer

Peidong Li,Jing Wen,Xiru Ren,Yu Zhou,Yuan Xue,ZaiHua Yan,Shengjie Li,Hongpeng Tian,Xuegui Tang,Guangjun Zhang

DOI: https://doi.org/10.21203/rs.3.rs-529744/v1

2021-05-26

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
Investigation of the Therapeutic Potential of Momelotinib on Hepatitis Virus-Associated Liver Cancer Is Through Suppressing Oncogenic/Stemnes IFNGR-JAK-STAT Pathway

Jiann Ruey Ong,Chi-Tai Yeh,Ting-Yi Huang,Ming-Shou Hsieh,Wei-Hwa Lee,Yih-Giun Cherng

DOI: https://doi.org/10.21203/rs.3.rs-106308/v1

2020-11-18

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
Global Profiling of Proteome, Lysine Acetylome and Succinylome Identifying Silica Injuries in Mice Lung

Mingyao Wang,Jiangfeng Liu,Tiantian Zhang,Zhe Zhang,Junling Pang,Yanjiang Xing,Ying Liu,Meiyue Song,Baicun Li,Juntao Yang,Jing Wang,Chen Wang

DOI: https://doi.org/10.21203/rs.3.rs-535726/v1

2021-01-01

Abstract:The authors have requested that this preprint be removed from Research Square.
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

Yi Zhou,Zhigang Ji,Weigang Yan,Zhien Zhou,Hanzhong Li,Yu Xiao

DOI: https://doi.org/10.3892/or.2024.8811

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion assay data shown in Fig. 3B on p. 839 were strikingly similar to data that had already appeared in another article written by different authors at different research institutes [Mao Y, Zhang L, Yuan L, Yan M and He Y: MiR‑218 suppresses cell progression by targeting APC in cervical cancer. Int J Clin Exp Pathol: 10, 2259‑2269, 2017]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 837‑842, 2017; DOI: 10.3892/or.2017.5768].
Transcriptomic Alterations Induced by Vemurafenib After Treatment of Melanoma: A Comprehensive Bioinformatics Analysis

Jiaheng Xie,Yuan Cao,Zhechen Zhu,Shujie Ruan,Ming Wang,Jingping Shi

DOI: https://doi.org/10.21203/rs.3.rs-509411/v2

2021-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
L1-ATP8B1 Exacerbates High-Level Reduction-Oxidation Homeostasis to Promote Carcinogenesis Via Affecting PHB1 Sumoylation in LUSC

Rui Zhang,Xiao Zhang,Zeguo Sun,Pengpeng Liu,Guidong Chen,Weijia Zhang,Jinpu Yu

DOI: https://doi.org/10.21203/rs.3.rs-1434039/v1

IF: 11.2

2024-01-01

Cancer Research

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
TGM3 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinogenesis and Predicts Poor Prognosis for Patients after Curative Resection.

Jin-Wu Hu,Zhang-fu Yang,Jia Li,Bo Hu,Chu-Bin Luo,Kai Zhu,Zhi Dai,Jia-Bin Cai,Hao Zhan,Zhi-Qiang Hu,Jie Hu,Ya Cao,Shuang-Jian Qiu,Jian Zhou,Jia Fan,Xiao-Wu Huang

DOI: https://doi.org/10.1016/j.dld.2019.10.010

2020-01-01

Abstract:Background: Prognosis of hepatocellular carcinoma (HCC) remains poor despite significant recent improvement in therapy. Recent studies have reported that transglutaminase 3 (TGM3) plays an important role in several human cancer types. However, the role of TGM3 in HCC have not been previously elucidated. Methods: We evaluated the role of TGM3 in regulating HCC cell proliferation, migration, and invasion. We also investigated the prognostic significance of TGM3 in an HCC cohort. Finally, we explored the signalling pathways that TGM3 regulates in HCC. Results: We identified TGM3 to be overexpressed in HCC compared to normal tissues. Higher expression of TGM3 predicts poor prognosis in HCC patients. TGM3 knockdown led to decreased HCC cell proliferation, invasion, and xenograft tumour growth. TGM3 depletion inhibited AKT, extracellular signal-regulated kinase (ERK), p65, and glycogen synthase kinase 3 beta (GSK3 beta)/beta-catenin activation, but promoted levels of cleaved caspase 3. Moreover, TGM3 knockdown cells had increased E-cadherin levels and decreased vimentin levels, suggesting that TGM3 contributes to epithelial-mesenchymal transition (EMT) in HCC. Conclusion: Our results suggest that TGM3 controls multiple oncogenic pathways in HCC, thereby contributing to increased cell proliferation and EMT, and TGM3 potentially enhances HCC metastasis. TGM3 may serve as a novel therapeutic target in HCC. (C) 2019 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Xiaoping Pan,Chen Wang,Yan Li,Lida Zhu,Ti Zhang

DOI: https://doi.org/10.1016/j.lfs.2018.10.064

IF: 6.78

2018-01-01

Life Sciences

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).This article has been retracted at the request of the Editor-in-Chief and the authors, as panels from Figure 6F appear as similar to panels from Figure 2B of the article published by Ming-Quan Gao, Hui Gao, Mei Han, Kai-Li Liu, Jian-Jun Peng and Yan-Tao Han in the American Journal of Cancer Research 7 (2017) 1501–1514 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523031/ and Figures 2E and 3E of the article published by Meizhi Wang, Hui Gao, Haijun Qu, Jing Li, Kaili Liu and Zhiwu Han in Pharmacological Reports 70 (2018) 963–971 https://doi.org/10.1016/j.pharep.2018.04.006.Also, the Vehicle panel from Figure 7E appears as similar to the Vehicle panel from Figure 3D of the article published by Bo Liu and Shuo Yu in Biomedicine & Pharmacotherapy 107 (2018) 243–253 https://doi.org/10.1016/j.biopha.2018.07.177.Figure 7E appears also as similar to Figure 6(b) of the article published by Mei Han, Hui Gao, Jing Xie, Yin-ping Yuan, Quan Yuan, Ming-quan Gao, Kai-li Liu, Xue-hong Chen, Yan-tao Han and Zhi-wu Han in Acta Pharmacologica Sinica volume 40 (2019) 666–676 https://doi.org/10.1038/s41401-018-0159-7.Moreover, panels from Figure 7F appear as similar to panels from Figure 7E of the Reference [1], Figure 6D of the Reference [2], Figure 6C of the Reference [3], Figure 8C of the Reference [4], Figure 8D of the Reference [5] and Figure 6B of the Reference [6].One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
Low Levels of Tumor Suppressor Candidate 3 Predict Poor Prognosis of Patients with Hepatocellular Carcinoma

Xu-Ren Shen,Song-Ge Xing,Run-Dong Wang,Kang Chen,Wei-Dong Jia

DOI: https://doi.org/10.2147/ott.s153381

IF: 4

2018-01-01

OncoTargets and Therapy

Abstract:Purpose: The tumor suppressor candidate 3 (TUSC3) has been considered to be closely associated with the occurrence, development and invasion of various malignant tumors. However, the expression of TUSC3 in hepatocellular carcinoma (HCC) tissues remains ambiguous. The purpose of this research was to investigate the expression of TUSC3 in HCC tissues and analyze the relationship between TUSC3 levels and clinicopathological characteristics and prognosis of HCC patients. Materials and methods: Immunohistochemistry was used to detect the expression of TUSC3 in HCC and the corresponding para-cancerous tissues from 92 samples of HCC patients. mRNA and protein expression levels of TUSC3 were evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot assays in 25 paired HCC and corresponding adjacent nontumor tissues. Furthermore, statistical analysis was applied to evaluate the correlation between TUSC3 level and the clinicopathological features and prognosis of HCC patients. Results: Immunohistochemical assay indicated that the expression of TUSC3 was significantly lower in HCC tissues when compared with the corresponding para-cancerous tissues (chi(2)=11.512, P=0.001). The analysis of clinicopathological characteristics showed that low expression of TUSC3 in HCC tissues was significantly associated with Edmondson grade, Barcelona Clinic Liver Cancer stage and tumor size (P=0.008, 0.009 and 0.020, respectively). Univariate analysis showed that the expression of TUSC3 was strongly correlated with overall survival (OS) and disease-free survival (DFS) after radical surgery in HCC patients (P<0.001, P<0.001, respectively). Multivariate analysis revealed that the TUSC3 level was an independent risk factor for OS and DFS in HCC patients (P=0.001, P<0.001, respectively). Results of qRT-PCR and Western blot assays indicated that the level of TUSC3 in HCC tissues was significantly lower than that in the corresponding adjacent noncancerous tissues (P<0.01, P<0.001). Conclusion: The expression of TUSC3 in HCC was significantly downregulated and was correlated with tumor progression and prognosis, which could be used as an independent predictor of prognosis in HCC patients.
Mir-542-3p Inhibits Metastasis And Epithelial- Mesenchymal Transition Of Hepatocellular Carcinoma By Targeting Ube3c

Jie Tao,Zhikui Liu,Yufeng Wang,Liang Wang,Bowen Yao,Qing Li,Cong Wang,Kangsheng Tu,Qingguang Liu

DOI: https://doi.org/10.1016/j.biopha.2017.06.070

IF: 7.419

2017-01-01

Biomedicine & Pharmacotherapy

Abstract:Accumulating evidence demonstrates that aberrant miRNAs contribute to hepatocellular carcinoma (HCC) development and progression. However, the roles of various miRNAs in HCC remain to be determined. In present research, we confirmed that a reduced miR-542-3p expression was present in HCC tissues and cell lines. Our clinical analysis revealed that the down-regulated miR-542-3p expression was significantly correlated with poor prognostic features including advanced TNM stage and venous infiltration. Moreover, we confirmed that miR-542-3p was a novel independent prognostic marker for predicting 5-year survival of HCC patients. The ectopic overexpression of miR-542-3p inhibited cell migration, invasion and EMT progress, while down-regulated miR-542-3p reversed the effect. In addition, miR-542-3p could regulate UBE3C by directly binding to its 30-UTR. In clinical samples of HCC, miR-542-3p inversely correlated with UBE3C, which was upregulated in HCC. Alternation of UBE3C expression at least partially abolished the migration, invasion and EMT progress effects of miR-542-3p on HCC cells. In conclusion, our results indicated that miR-542-3p functioned as a tumor suppressor gene in regulating the EMT and metastasis of HCC via targeting UBE3C, and may represent a novel potential therapeutic target and prognostic marker for HCC. (C) 2017 Elsevier Masson SAS. All rights reserved.
Down-regulation of Sirtuin 3 is Associated with Poor Prognosis in Hepatocellular Carcinoma after Resection

Jia-Xing Wang,Yong Yi,Yi-Wei Li,Xiao-Yan Cai,Hong-Wei He,Xiao-Chun Ni,Jian Zhou,Yun-Feng Cheng,Jian-Jun Jin,Jia Fan,Shuang-Jian Qiu

DOI: https://doi.org/10.1186/1471-2407-14-297

IF: 4.638

2014-01-01

BMC Cancer

Abstract:Background Sirtuin 3 (Sirt3), one of the seven Sirtuins family members, plays critical roles in the progression of multiple cancer types. However, its role in the prognosis of hepatocellular carcinoma (HCC) has not yet been investigated systematically. Methods The correlation of Sirtuins expression with prognosis of HCC was determined by immunohistochemistry (IHC) in a large HCC patient cohort (n = 342). Expression of Sirt3 in tumoral and peritumoral tissues of HCC patients were further determined by western blotting (WB). Results IHC and WB studies both showed a decreased expression of Sirt3 in tumoral tissues compared with peritumoral tissues ( P = 0.003 for IHC, P = 0.0042 for WB). Decreased expression of Sirt3 in both tumoral and peritumoral tissues was associated with increased recurrence probability and decreased overall survival rate by univariate analyses (intratumoral Sirt3: P = 0.011 for TTR, P = 0.001 for OS; peritumoral Sirt3: P = 0.017 for TTR, P = 0.023 for OS), the prognostic value was strengthened by multivariate analyses (intratumoral Sirt3: P = 0.031 for TTR, P = 0.001 for OS; peritumoral Sirt3: P = 0.047 for TTR, P = 0.031 for OS). Intratumoral Sirt3 also showed a favorable prognostic value in patients with BCLC stage A (TTR, P = 0.011; OS, P < 0.001). In addition, we found that IHC studies of other sirtuin members showed a decreased expression of Sirt2, Sirt4 and Sirt5 and an increased expression of Sirt1, Sirt6 and Sirt7 in intratumoral tissues compared with peritumoral tissues. In contrast to Sirt3, other members did not showed a remarkable correlation with HCC prognosis. Conclusions Down-regulation of intratumoral and peritumoral Sirt3 were both associated with poor outcome in HCC, moreover, intratumoral Sirt3 was a favorable prognostic predictor in early stage patients.
WITHDRAWN: Marsdenia Tenacissima Extract Activates FoxO3a Nuclear Translocation to Promote Apoptosis Via Inhibiting Autophagy in Prostate Cancer

Qiuping Zhang,Qiuju Huang,Zhiping Cheng,Wei Xue,Shoushi Liu,Yunnuo Liao,Jie Hao,Xin Chen,Xiaolan Li,Yaoyao Han,Dan Zhu,Zhiheng Su,Xin Yang,Zhuo Luo,Hongwei Guo

DOI: https://doi.org/10.1016/j.phymed.2022.154560

IF: 6.656

2022-01-01

Phytomedicine

Abstract:This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

3-Mercaptopyruvate Sulfurtransferase Represses Tumor Progression and Predicts Prognosis in Hepatocellular Carcinoma

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study

3‐Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma

METTL3 is a Potential Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma

The Sulfatide/Myb/MEF2C Axis Controls the Malignant Behaviors of Hepatocellular Carcinoma Cells by Modulating Lncay Expression

SRSF10 inhibition prevents HCC growth and metastasis and enhances the anti-PD-L1- mediated tumor suppression

Supplementary Data from Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3

RETRACTED: S1P3 Promotes Low-Grade Glioma Progression and Affects Tumor Microenvironment Infiltration

MiR-23b-3p Targeting NCAPG Promotes Cell Proliferation and Anti-Apoptosis By Regulating PI3K/AKT Signaling Pathway in Colorectal Cancer

Investigation of the Therapeutic Potential of Momelotinib on Hepatitis Virus-Associated Liver Cancer Is Through Suppressing Oncogenic/Stemnes IFNGR-JAK-STAT Pathway

Global Profiling of Proteome, Lysine Acetylome and Succinylome Identifying Silica Injuries in Mice Lung

[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

Transcriptomic Alterations Induced by Vemurafenib After Treatment of Melanoma: A Comprehensive Bioinformatics Analysis

L1-ATP8B1 Exacerbates High-Level Reduction-Oxidation Homeostasis to Promote Carcinogenesis Via Affecting PHB1 Sumoylation in LUSC

TGM3 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinogenesis and Predicts Poor Prognosis for Patients after Curative Resection.

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Low Levels of Tumor Suppressor Candidate 3 Predict Poor Prognosis of Patients with Hepatocellular Carcinoma

Mir-542-3p Inhibits Metastasis And Epithelial- Mesenchymal Transition Of Hepatocellular Carcinoma By Targeting Ube3c

Down-regulation of Sirtuin 3 is Associated with Poor Prognosis in Hepatocellular Carcinoma after Resection

WITHDRAWN: Marsdenia Tenacissima Extract Activates FoxO3a Nuclear Translocation to Promote Apoptosis Via Inhibiting Autophagy in Prostate Cancer